1Tallman MS, Rowlings PA, Milone G, et al. Effect of postrernission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute, mylogenous leukemia in first complete vemission. Bood ,2000,96:1254.
2Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of prerernission and postremission therapy in adult acute myeloid leukemia.-a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood, 2000,96: 4075.
3Korbling M and Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation:does the source of hematopoietic stem cells matter? Blood,2001,98:2900.
4Grewal SS, Barker JN, Davies SM, et al. Unrelated donor hematopoietic cell transplantation:marrow or umbilical cord blood?Blood, 2003,101:4233.
5Ottinger HD, Ferencik S, Beelen DW, et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood, 2003, 102:1131.
6Rood JJV,Loberiza FR,Jr, Zhang MJ,et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versushost disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood, 2002,99:1572.
7Farad SS,Fehniger T, Rugged L, et al. Natural killer cell receptors: new biology and insights into graft versus leukemia effect.Blood, 2002,100:1935.
8Rowe JM and Lazarus HM. Genetically haploidentical stem cell transplantation for acute leukemia. Bone Marrow Transplantation, 2001,27: 669.
